熱門資訊> 正文
默克集团公布第二季度业绩
2025-08-07 17:25
- Merck KGaA press release (OTCPK:MKGAF): Q2 GAAP EPS of €1.50.
- Revenue of €5.26B (-1.7% Y/Y).
- Merck refined its existing guidance for the full year. The company narrowed the expected organic sales growth range for the Group to 2% to 5% (previously 2% to 6%). For EBITDA pre, Merck raised its guidance and now expects organic growth of 4% to 8% (previously 2% to 7%). This change was driven by positive guidance adjustments for Life Science and Healthcare as well as high cost discipline in all business sectors.
More on Merck KGaA
- Merck KGaA: The Undervaluation Is Now Close To 13-Year Lows
- Merck KGaA 2025 Q1 - Results - Earnings Call Presentation
- Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript
- Merck KGaA gets EU nod for genetic disorder therapy
- Merck KGaA Non-GAAP EPS of €2.12, revenue of €5.28B; updates FY25 outlook
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。